Ginkgo Bioworks (DNA) announced the expansion of its strategic partnership with Novo Nordisk under a framework agreement that initially is contemplated to run over five years. The companies target to improve the manufacturing of Novo Nordisk's medicines for serious chronic diseases, including diabetes and obesity medications. The companies plan to collaborate on several early pipeline projects.
Jason Kelly, CEO and co-founder at Ginkgo Bioworks, said: "With this deal structure, Novo Nordisk can easily access the entire expanse of Ginkgo's pharma services from discovery through manufacturing."
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.